Skip to main content

Table 4 Details of inpatient care expenditure for treating diabetics with and without complications in Punjab

From: Cost of diabetes and its complications: results from a STEPS survey in Punjab, India

Cost variables

Group 1 (without complications)

Group 2 (with micro-vascular complications)

Group 3 (with macro-vascular complications)

Group 4 (with both complications)

Mean

Median (range)

Mean

Median (range)

Mean

Median (range)

Mean

Median (range)

Consultation fee (₹)

1365

700 (5600–100)

1713

1200 (8000–20)

1949

1500 (8000–200)

1650

1200 (5000–20)

Expenditure on medicines (₹)

4058

3400 (12,000–500)

5694

4000 (25,000–500)

6364

4800 (35,000–800)

5603

3650 (18,000–1000)

Hospitalization fees

5079

2250 (24,000–750)

5077

3500 (25,000–200)

6518

4900 (25,000–200)

4802

3000 (18,000–200)

Diagnostic expenditure (₹)

3561

2500 (12,600–250)

5495

4000 (42,000–250)

6547

5000 (24,000–250)

5345

3750 (18,000–250)

Transportation (₹)

322

350 (700–100)

906

500 (12,000–50)

533

4800 (4800–50)

452

275 (1000–50)

Food and other material

1516

1000 (5000–300)

2659

2000 (8000–200)

3032

2500 (9000–300)

2513

2000 (8000–300)

Other’s (Surgeries, etc.)

16,447

15,000 (35,500–200)

31,578

20,000 (160,000–200)

41,099

25,500 (160,000–200)

32,842

30,000 (155,000–200)

Total direct cost (₹)

20,767

14,000 (70,000–2500)

36,412

21,800 (234,000–3000)

48,001

28,000 (250,000–3000)

36,748

24,000 (200,000–3000)

Wage loss incurred by diabetic patients (₹)

2416

2000 (4500–400)

3411

2400 (18,000–400)

4587

3000 (18,000–500)

3251

1800 (18,000–500)

Wage loss incurred by accompanying person (₹)

2429

2000 (7400–400)

3496

2800 (20,000–300)

3127

2500 (20,000–300)

3260

2000 (20,000–300)

Total indirect cost (₹)

2525

2400 (7400–400)

4226

3000 (20,000–500)

5291

3150 (24,000–700)

4509

2750 (20,000–800)

  1. Source: Authors calculation established on primary data
  2. Group-1: No Complications (n = 48)
  3. Group-2: Microvascular complications (foot ulcer, retinopathy, neuropathy, nephropathy, periodontitis, vasculopathy) (n = 118)
  4. Group-3: Macrovascular complications (coronary artery disease, transient ischemic attack, hypoglycaemia, peripheral vascular disease) (n = 89)
  5. Group-4: Microvascular and Macrovascular Complications (n = 52)